Izotropic Corporation
CNQ: IZO.CN0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Canadian Securities Exchange
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Robert Louis Thast
- Headquarters
- Surrey, Canada
- IPO year
- 2018
- Market cap
- CA$21.7M
- Website
- https://izocorp.com
Loading IZO…
Loading profile data…Frequently asked questions about IZO
What does Izotropic Corporation (IZO.CN) do?
Izotropic Corporation, a MedTech company, commercializes diagnostic products for breast cancer. It develops and commercializes breast CT Imaging system; and 3D CT breast imaging platform for the earlier detection and diagnosis of breast cancer. The company was incorporated in 2016 and is headquartered in Surrey, Canada.
Where does IZO.CN trade?
Izotropic Corporation (IZO.CN) trades on the Canadian Securities Exchange.
What sector is IZO.CN in?
Izotropic Corporation (IZO.CN) operates in the Healthcare sector, specifically in the Medical - Diagnostics & Research industry.
Who is the CEO of Izotropic Corporation?
Robert Louis Thast is the chief executive officer of Izotropic Corporation (IZO.CN).
Where is Izotropic Corporation headquartered?
Izotropic Corporation is headquartered in Canada.
Does IZO.CN pay a dividend?
Izotropic Corporation (IZO.CN) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did IZO.CN go public?
Izotropic Corporation (IZO.CN) completed its initial public offering in 2018.